Europe Melanoma Therapeutics Market: Assessing the Impact of PD-1...

a adăugat un sunet Health

2025-12-04 10:12:18 - Translate -

Europe Melanoma Therapeutics Market: Assessing the Impact of PD-1 Inhibitors on Adjuvant Therapy

The Paradigm Shift in Preventing Recurrence for High-Risk Patients The introduction of PD-1 inhibitors into the adjuvant (post-surgery) treatment protocol has marked a monumental shift in the management of high-risk Stage III and, more recently, some Stage II melanoma cases in Europe. Before these immunotherapies, recurrence rates for these patients were tragically high, with limited options...

0 Commentarii 0 Distribuiri 227 Views